REQUEST A DEMO
Total
USD $0.00
Search more companies

PT Genero Pharmaceuticals (Indonesia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: PT Genero Pharmaceuticals Profile Updated: February 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

PT Genero Pharmaceuticals provides integrated services for dermatology, including research and development, clinical research organization, contract manufacturing, and quality control testing services for pharmaceutical, traditional medicine, food supplement, and cosmetic products. Genero has expertise in creating dermatology products for all ages and body parts, collaborating with over 170 dermatologists.

Headquarters
District 8, Sudirman Central Business District (SCBD) Lot 28
South Jakarta; Jakarta; Postal Code: 12190

Contact Details: Purchase the PT Genero Pharmaceuticals report to view the information.

Website: http://www.genero.co.id

Basic Information
Total Employees:
Purchase the PT Genero Pharmaceuticals report to view the information.
Outstanding Shares:
Purchase the PT Genero Pharmaceuticals report to view the information.
Registered Capital:
Purchase the PT Genero Pharmaceuticals report to view the information.
Incorporation Date:
2000
Key Executives
Purchase this report to view the information.
President Commissioner
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Pt. Derma Lab Asia
Pt. Genero Pharmaceuticals
Company Performance
Financial values in the chart are available after PT Genero Pharmaceuticals report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
2.95%
Total operating revenue
2.95%
Total assets
2.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?